LAB Standard BioTools Corp: Expected earnings per share growth for next year
The EPS growth forecast model for the coming year demonstrates a trend where the -59.80 mark serves as the current indicator. Standard BioTools Inc. revenues are based on government contracts and the R&D budgets of pharma behemoths. The company maintains technological superiority in genomics thanks to colossal investments in equipment. The business is currently scaling operations and optimizing costs, extracting synergy following a large-scale consolidation of assets.
Analytical breakdowns for fluidigm.com (LAB)
- price and consensus price forecast:
- company stock capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
Total Debt to Capital Standard BioTools Inc.|LAB - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Standard BioTools|LAB - Company Aggregate Debts|Debt to Book Capitalization Ratio Standard BioTools|LAB - Company Long-Term Loans and Borrowings|Company Short-Term Debts Standard BioTools|Quick Liquidity Indicator fluidigm.com
- earnings and valuation multiples information:
LAB - Final Profit|Projected Future Earnings Standard BioTools Inc.|LAB - Price to Earnings Ratio|Forward P/E Multiple Standard BioTools Inc.|LAB - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Standard BioTools|LAB - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Standard BioTools|LAB - Earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months fluidigm.com|LAB - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Standard BioTools Inc.
Basic company analysis:LAB, Fluidigm
Standard BioTools Inc. (LAB) is facing a prolonged recovery in demand for laboratory equipment and merger-related costs, which is delaying the achievement of net profitability. This forward earnings per share growth forecast quantifies market expectations for EPS dynamics, allowing for an assessment of the business's ability to offset cost inflation, while the upward trend on the chart signals increasing efficiency but raises the risk of overpaying for the asset.
Competitor analysis for Standard BioTools Inc.
Net earnings per share growth forecast for next year Agilent Tech|Quest Corp (DGX) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year ILMN (Illumina, Inc.)|Projected earnings per share increase next year EXAS|Earnings growth forecast for next year RVTY (Revvity)|Earnings growth forecast for next year Bio-Rad Laboratories, Inc. BIO|NNNN - Net earnings per share growth forecast for next year|SHC (Nordion) - Projected earnings per share growth rate for next year|QDEL: Earnings growth forecast for next year|Projected earnings per share growth rate for next year OPK|CDNA (CareDx, Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year Maravai LifeSciences Holdings|Net earnings per share growth forecast for next year Fulgent Corp (FLGT)|CTKB (Cytek Corp) - Expected earnings per share trend next year|Earnings growth forecast for next year OSUR (OraSure Technologies)|XGN: Projected earnings per share growth rate for next year|MDXH: Expected earnings per share growth for next year|Expected earnings per share trend next year LUCD (Lucid Diagnostics, Inc.)|PRE: Earnings growth forecast for next year|IMDX (Insight Molecular Diagnostics Inc) - Net earnings per share growth forecast for next year|TRIB (Trinity Biotech PLC) - Earnings growth forecast for next year|prophaselabs.com (PRPH) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Ainos (AIMD)|CODX - Expected net earnings per share growth next year|Heart Test Laboratories Inc. - Expected earnings per share growth for next year|Projected earnings per share increase next year BMRA (Biomerica Inc)|CDIO - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year onconetix.gcs-web.com|Virax Biolabs (VRAX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Bluejay Diagnostics Inc (BJDX)|Net earnings per share growth forecast for next year Vermillion|Net earnings per share growth forecast for next year AXDX|Net earnings per share growth forecast for next year Centogene NV (CNTG)|Consensus forecast of earnings per share growth for next year enzo.com|Fresh2 Group - Expected earnings per share growth for next year|Expected earnings per share trend next year GENE|23andMe Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Psychemedics Inc PMD
